Quantum Biopharma Ltd
(QNTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 16,136 | 23,790 | 27,430 | 33,744 | 30,691 |
| Operating Income | -16,136 | -23,790 | -27,430 | -33,744 | -30,691 |
| Interest Expense | 33 | 0 | 49 | 69 | 236 |
| Other Income | 1,254 | 5,559 | 775 | -125 | 2,475 |
| Pre-tax Income | -14,916 | -18,231 | -26,704 | -33,938 | -28,452 |
| Net Income Continuous | -14,916 | -18,231 | -26,704 | -33,938 | -28,452 |
| Net Income Discontinuous | N/A | N/A | 3,097 | -1,348 | -3,348 |
| Minority Interests | -713 | -328 | N/A | N/A | N/A |
| Net Income | $-14,203 | $-17,902 | $-23,607 | $-35,285 | $-31,800 |
| EPS Basic Total Ops | -13.12 | -29.93 | -39.61 | -65.58 | -171.43 |
| EPS Basic Continuous Ops | -13.12 | -29.94 | -44.77 | -63.06 | -153.40 |
| EPS Basic Discontinuous Ops | N/A | N/A | 5.19 | -2.50 | -18.05 |
| EPS Diluted Total Ops | -13.12 | -29.93 | -39.61 | -65.58 | -171.43 |
| EPS Diluted Continuous Ops | -13.12 | -29.94 | -44.77 | -63.06 | -153.40 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 5.19 | -2.50 | -18.05 |
| EPS Diluted Before Non-Recurring Items | -13.12 | -29.87 | -44.81 | -62.99 | -142.86 |
| EBITDA(a) | $-15,646 | $-21,283 | $-22,895 | $-29,698 | $-26,791 |